An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

The findings suggest -- for the first time in a clinical trial -- that early treatment to remove amyloid plaques from the ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

The anti-amyloid therapy gantenerumab lowered the chances for developing Alzheimer’s-related dementia in people at high risk for the disease, according to a small study conducted by the Knight Family ...

A new study suggests a promising alternative to previous attempts to remove the sticky, toxic amyloid beta plaques from brains with Alzheimer's Disease: enhancing the brain's own immune cells to clear ...

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky ...

Notably, microglia spatially associated with amyloid plaques exhibited increased expression of TREM2 and ApoE compared to ...

Amyloid beta is a small protein fragment that forms plaque-like deposits when it accumulates abnormally in the brain. Vaccination is supposed to trigger the immune system to produce antibodies to ...